MicroRNA expression profiles in serous ovarian carcinoma

Eun Ji Nam, Heejei Yoon, Sang Wun Kim, Hoguen Kim, YoungTae Kim, Jae-Hoon Kim, Jae Wook Kim, Sunghoon Kim

Research output: Contribution to journalArticle

598 Citations (Scopus)

Abstract

Purpose: Although microRNAs have recently been recognized as riboregulators of gene expression, little is known about microRNA expression profiles in serous ovarian carcinoma. We assessed the expression of microRNA and the association between microRNA expression and the prognosis of serous ovarian carcinoma. Experimental Design: Twenty patients diagnosed with serous ovarian carcinoma and eight patients treated for benign uterine disease between December 2000 and September 2003 were enrolled in this study. The microRNA expression profiles were examined using DNA microarray and Northern blot analyses. Resilts: Several microRNAs were differentially expressed in serous ovarian carcinoma compared with normal ovarian tissues, including miR-2l miR-125a, miR-125b, miR-100, miR-145, miR-16, and miR-99a, which were each differentially expressed in >16 patients. In addition, the expression levels of some microRNAs were correlated with the survival in patients with serous ovarian carcinoma. Higher expression of miR-200, miR-141, miR-18a, miR-93, and miR-429, and lower expression of let-7, and miR-199a were significantly correlated with a poor prognosis (P < 0.05). Conlusion: Our results indicate that dysregulation of microRNAs is involved in ovarian carcinogenesis and associated with the prognosis of serous ovarian carcinoma.

Original languageEnglish
Pages (from-to)2690-2695
Number of pages6
JournalClinical Cancer Research
Volume14
Issue number9
DOIs
Publication statusPublished - 2008 May 1

Fingerprint

MicroRNAs
Carcinoma
Uterine Diseases
Oligonucleotide Array Sequence Analysis
Northern Blotting
Carcinogenesis
Research Design
Gene Expression
Survival

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Nam, Eun Ji ; Yoon, Heejei ; Kim, Sang Wun ; Kim, Hoguen ; Kim, YoungTae ; Kim, Jae-Hoon ; Kim, Jae Wook ; Kim, Sunghoon. / MicroRNA expression profiles in serous ovarian carcinoma. In: Clinical Cancer Research. 2008 ; Vol. 14, No. 9. pp. 2690-2695.
@article{a76bb7ce40fb4826810b6a7a5d20e9a4,
title = "MicroRNA expression profiles in serous ovarian carcinoma",
abstract = "Purpose: Although microRNAs have recently been recognized as riboregulators of gene expression, little is known about microRNA expression profiles in serous ovarian carcinoma. We assessed the expression of microRNA and the association between microRNA expression and the prognosis of serous ovarian carcinoma. Experimental Design: Twenty patients diagnosed with serous ovarian carcinoma and eight patients treated for benign uterine disease between December 2000 and September 2003 were enrolled in this study. The microRNA expression profiles were examined using DNA microarray and Northern blot analyses. Resilts: Several microRNAs were differentially expressed in serous ovarian carcinoma compared with normal ovarian tissues, including miR-2l miR-125a, miR-125b, miR-100, miR-145, miR-16, and miR-99a, which were each differentially expressed in >16 patients. In addition, the expression levels of some microRNAs were correlated with the survival in patients with serous ovarian carcinoma. Higher expression of miR-200, miR-141, miR-18a, miR-93, and miR-429, and lower expression of let-7, and miR-199a were significantly correlated with a poor prognosis (P < 0.05). Conlusion: Our results indicate that dysregulation of microRNAs is involved in ovarian carcinogenesis and associated with the prognosis of serous ovarian carcinoma.",
author = "Nam, {Eun Ji} and Heejei Yoon and Kim, {Sang Wun} and Hoguen Kim and YoungTae Kim and Jae-Hoon Kim and Kim, {Jae Wook} and Sunghoon Kim",
year = "2008",
month = "5",
day = "1",
doi = "10.1158/1078-0432.CCR-07-1731",
language = "English",
volume = "14",
pages = "2690--2695",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "9",

}

MicroRNA expression profiles in serous ovarian carcinoma. / Nam, Eun Ji; Yoon, Heejei; Kim, Sang Wun; Kim, Hoguen; Kim, YoungTae; Kim, Jae-Hoon; Kim, Jae Wook; Kim, Sunghoon.

In: Clinical Cancer Research, Vol. 14, No. 9, 01.05.2008, p. 2690-2695.

Research output: Contribution to journalArticle

TY - JOUR

T1 - MicroRNA expression profiles in serous ovarian carcinoma

AU - Nam, Eun Ji

AU - Yoon, Heejei

AU - Kim, Sang Wun

AU - Kim, Hoguen

AU - Kim, YoungTae

AU - Kim, Jae-Hoon

AU - Kim, Jae Wook

AU - Kim, Sunghoon

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Purpose: Although microRNAs have recently been recognized as riboregulators of gene expression, little is known about microRNA expression profiles in serous ovarian carcinoma. We assessed the expression of microRNA and the association between microRNA expression and the prognosis of serous ovarian carcinoma. Experimental Design: Twenty patients diagnosed with serous ovarian carcinoma and eight patients treated for benign uterine disease between December 2000 and September 2003 were enrolled in this study. The microRNA expression profiles were examined using DNA microarray and Northern blot analyses. Resilts: Several microRNAs were differentially expressed in serous ovarian carcinoma compared with normal ovarian tissues, including miR-2l miR-125a, miR-125b, miR-100, miR-145, miR-16, and miR-99a, which were each differentially expressed in >16 patients. In addition, the expression levels of some microRNAs were correlated with the survival in patients with serous ovarian carcinoma. Higher expression of miR-200, miR-141, miR-18a, miR-93, and miR-429, and lower expression of let-7, and miR-199a were significantly correlated with a poor prognosis (P < 0.05). Conlusion: Our results indicate that dysregulation of microRNAs is involved in ovarian carcinogenesis and associated with the prognosis of serous ovarian carcinoma.

AB - Purpose: Although microRNAs have recently been recognized as riboregulators of gene expression, little is known about microRNA expression profiles in serous ovarian carcinoma. We assessed the expression of microRNA and the association between microRNA expression and the prognosis of serous ovarian carcinoma. Experimental Design: Twenty patients diagnosed with serous ovarian carcinoma and eight patients treated for benign uterine disease between December 2000 and September 2003 were enrolled in this study. The microRNA expression profiles were examined using DNA microarray and Northern blot analyses. Resilts: Several microRNAs were differentially expressed in serous ovarian carcinoma compared with normal ovarian tissues, including miR-2l miR-125a, miR-125b, miR-100, miR-145, miR-16, and miR-99a, which were each differentially expressed in >16 patients. In addition, the expression levels of some microRNAs were correlated with the survival in patients with serous ovarian carcinoma. Higher expression of miR-200, miR-141, miR-18a, miR-93, and miR-429, and lower expression of let-7, and miR-199a were significantly correlated with a poor prognosis (P < 0.05). Conlusion: Our results indicate that dysregulation of microRNAs is involved in ovarian carcinogenesis and associated with the prognosis of serous ovarian carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=50849137458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=50849137458&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-07-1731

DO - 10.1158/1078-0432.CCR-07-1731

M3 - Article

C2 - 18451233

AN - SCOPUS:50849137458

VL - 14

SP - 2690

EP - 2695

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 9

ER -